Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies
Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variabili...
Gespeichert in:
Veröffentlicht in: | Respiratory medicine 2016-08, Vol.117, p.154-161 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 161 |
---|---|
container_issue | |
container_start_page | 154 |
container_title | Respiratory medicine |
container_volume | 117 |
creator | Matte, Darlan L Pizzichini, Marcia M.M Hoepers, Andrea T.C Diaz, Alexandre P Karloh, Manuela Dias, Mirella Pizzichini, Emilio |
description | Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size >100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates. |
doi_str_mv | 10.1016/j.rmed.2016.06.006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1809608593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0954611116301305</els_id><sourcerecordid>1809608593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoMo7tnVP-CFBLzxpsfJR9NWRFjO-gULu6BeSkjTKeTYNsdMq5x_b8rZRdgLYWACed6BeYaxFwK2AoR5s9-mEbutzO8t5ALziG1EqWShwOjHbANNqQsjhDhj50R7AGi0hqfsTFa6kaU0G_bjNuFvN-Dkkceed3hISBTixMPEdze3V2_5JacjzTi6OXie6YB_uJs6PuLsCje54UiB1rCP05ziMGDHaV66gPSMPendQPj8rl-w7x8_fNt9Lq5vPn3ZXV4XvtTNXLjKKd2Dd9CLtm4r07W6qk2FvvK6Vq0XqmlNnXsptHeu0XVljHS18r5VyqkL9vo095DirwVptmMgj8PgJowLWVFDY6AuG5XRVw_QfVxS3uJESWFq2WRKniifIlHC3h5SGF06WgF2lW_3dpVvV_kWcoHJoZd3o5d2_buP3NvOwLsTgNlF9pgs-bCq70JCP9suhv_Pf_8g7ocwBe-Gn3hE-reHJWnBfl3Pv15fGAVCQan-Ah9RqdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1809216829</pqid></control><display><type>article</type><title>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Matte, Darlan L ; Pizzichini, Marcia M.M ; Hoepers, Andrea T.C ; Diaz, Alexandre P ; Karloh, Manuela ; Dias, Mirella ; Pizzichini, Emilio</creator><creatorcontrib>Matte, Darlan L ; Pizzichini, Marcia M.M ; Hoepers, Andrea T.C ; Diaz, Alexandre P ; Karloh, Manuela ; Dias, Mirella ; Pizzichini, Emilio</creatorcontrib><description>Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size >100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.</description><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2016.06.006</identifier><identifier>PMID: 27492526</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age ; Aged ; Chronic obstructive pulmonary disease ; Comorbidity ; COPD ; Depression ; Depression - complications ; Depression - epidemiology ; Depression - etiology ; Female ; Hospitals ; Humans ; Male ; Mental depression ; Meta-analysis ; Middle Aged ; Mortality ; Population ; Prevalence ; Pulmonary Disease, Chronic Obstructive - complications ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - psychology ; Pulmonary/Respiratory ; Quality ; Review ; Severity of Illness Index ; Smoking - epidemiology ; Spirometry ; Studies ; Systematic review</subject><ispartof>Respiratory medicine, 2016-08, Vol.117, p.154-161</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 01, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</citedby><cites>FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0954611116301305$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27492526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matte, Darlan L</creatorcontrib><creatorcontrib>Pizzichini, Marcia M.M</creatorcontrib><creatorcontrib>Hoepers, Andrea T.C</creatorcontrib><creatorcontrib>Diaz, Alexandre P</creatorcontrib><creatorcontrib>Karloh, Manuela</creatorcontrib><creatorcontrib>Dias, Mirella</creatorcontrib><creatorcontrib>Pizzichini, Emilio</creatorcontrib><title>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><description>Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size >100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.</description><subject>Age</subject><subject>Aged</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>COPD</subject><subject>Depression</subject><subject>Depression - complications</subject><subject>Depression - epidemiology</subject><subject>Depression - etiology</subject><subject>Female</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Male</subject><subject>Mental depression</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Population</subject><subject>Prevalence</subject><subject>Pulmonary Disease, Chronic Obstructive - complications</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - psychology</subject><subject>Pulmonary/Respiratory</subject><subject>Quality</subject><subject>Review</subject><subject>Severity of Illness Index</subject><subject>Smoking - epidemiology</subject><subject>Spirometry</subject><subject>Studies</subject><subject>Systematic review</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1TAQhoMo7tnVP-CFBLzxpsfJR9NWRFjO-gULu6BeSkjTKeTYNsdMq5x_b8rZRdgLYWACed6BeYaxFwK2AoR5s9-mEbutzO8t5ALziG1EqWShwOjHbANNqQsjhDhj50R7AGi0hqfsTFa6kaU0G_bjNuFvN-Dkkceed3hISBTixMPEdze3V2_5JacjzTi6OXie6YB_uJs6PuLsCje54UiB1rCP05ziMGDHaV66gPSMPendQPj8rl-w7x8_fNt9Lq5vPn3ZXV4XvtTNXLjKKd2Dd9CLtm4r07W6qk2FvvK6Vq0XqmlNnXsptHeu0XVljHS18r5VyqkL9vo095DirwVptmMgj8PgJowLWVFDY6AuG5XRVw_QfVxS3uJESWFq2WRKniifIlHC3h5SGF06WgF2lW_3dpVvV_kWcoHJoZd3o5d2_buP3NvOwLsTgNlF9pgs-bCq70JCP9suhv_Pf_8g7ocwBe-Gn3hE-reHJWnBfl3Pv15fGAVCQan-Ah9RqdA</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Matte, Darlan L</creator><creator>Pizzichini, Marcia M.M</creator><creator>Hoepers, Andrea T.C</creator><creator>Diaz, Alexandre P</creator><creator>Karloh, Manuela</creator><creator>Dias, Mirella</creator><creator>Pizzichini, Emilio</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20160801</creationdate><title>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</title><author>Matte, Darlan L ; Pizzichini, Marcia M.M ; Hoepers, Andrea T.C ; Diaz, Alexandre P ; Karloh, Manuela ; Dias, Mirella ; Pizzichini, Emilio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-a7a34f0ca0f1b8b76db47867ec7c483bc139b68bc1514caa9487662a83ccb33a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Age</topic><topic>Aged</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>COPD</topic><topic>Depression</topic><topic>Depression - complications</topic><topic>Depression - epidemiology</topic><topic>Depression - etiology</topic><topic>Female</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Male</topic><topic>Mental depression</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Population</topic><topic>Prevalence</topic><topic>Pulmonary Disease, Chronic Obstructive - complications</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - psychology</topic><topic>Pulmonary/Respiratory</topic><topic>Quality</topic><topic>Review</topic><topic>Severity of Illness Index</topic><topic>Smoking - epidemiology</topic><topic>Spirometry</topic><topic>Studies</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matte, Darlan L</creatorcontrib><creatorcontrib>Pizzichini, Marcia M.M</creatorcontrib><creatorcontrib>Hoepers, Andrea T.C</creatorcontrib><creatorcontrib>Diaz, Alexandre P</creatorcontrib><creatorcontrib>Karloh, Manuela</creatorcontrib><creatorcontrib>Dias, Mirella</creatorcontrib><creatorcontrib>Pizzichini, Emilio</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matte, Darlan L</au><au>Pizzichini, Marcia M.M</au><au>Hoepers, Andrea T.C</au><au>Diaz, Alexandre P</au><au>Karloh, Manuela</au><au>Dias, Mirella</au><au>Pizzichini, Emilio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>117</volume><spage>154</spage><epage>161</epage><pages>154-161</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><abstract>Abstract Background Depression is frequently reported in association with COPD. However, the prevalence of depression in these patients ranges largely. This study aimed to systematically review the prevalence of depression in COPD and controls and to explore remaining causes of inter-study variability in the reported prevalence. Methods A systemic review of the literature and a meta-analysis was performed to evaluate the source of variability in the reported rates of depression in stable COPD. Main eligibility criteria were: controlled studies with a sample size >100, outpatients with COPD diagnosed by spirometry and, use of a validated depression screening instrument. Results From 1613 studies identified, eight controlled studies were included in the review. The number of participants in the pooled studies was of 5.552 COPD subjects and 5.211 controls. Using stricter criteria for study selection reduced the variability of the depression prevalence in COPD and controls, which was 27.1% [25.9–28.3] in COPD subjects and 10.0% [9.2–10.8] in the control group. The pooled odds ratio and 95% CI was 3.74 [2.4–5.9]. However, the heterogeneity across studies was high. Possible explanatory factor included sample sizes, COPD/controls ratio, smoker’s/nonsmokers ratio and qualitative differences (source of subjects, instruments to screen depression, COPD severity, smoking status, and comorbidities). Conclusion The study highlights the variability in estimates of depression prevalence in COPD. It could be explained by methodological differences across the included studies. This suggests that a standardization is critical to improve precision of the estimates.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27492526</pmid><doi>10.1016/j.rmed.2016.06.006</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0954-6111 |
ispartof | Respiratory medicine, 2016-08, Vol.117, p.154-161 |
issn | 0954-6111 1532-3064 |
language | eng |
recordid | cdi_proquest_miscellaneous_1809608593 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Age Aged Chronic obstructive pulmonary disease Comorbidity COPD Depression Depression - complications Depression - epidemiology Depression - etiology Female Hospitals Humans Male Mental depression Meta-analysis Middle Aged Mortality Population Prevalence Pulmonary Disease, Chronic Obstructive - complications Pulmonary Disease, Chronic Obstructive - epidemiology Pulmonary Disease, Chronic Obstructive - physiopathology Pulmonary Disease, Chronic Obstructive - psychology Pulmonary/Respiratory Quality Review Severity of Illness Index Smoking - epidemiology Spirometry Studies Systematic review |
title | Prevalence of depression in COPD: A systematic review and meta-analysis of controlled studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A35%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20depression%20in%20COPD:%20A%20systematic%20review%20and%20meta-analysis%20of%20controlled%20studies&rft.jtitle=Respiratory%20medicine&rft.au=Matte,%20Darlan%20L&rft.date=2016-08-01&rft.volume=117&rft.spage=154&rft.epage=161&rft.pages=154-161&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2016.06.006&rft_dat=%3Cproquest_cross%3E1809608593%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1809216829&rft_id=info:pmid/27492526&rft_els_id=1_s2_0_S0954611116301305&rfr_iscdi=true |